Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - Chile

Chile

In Chile, the revenue generated in the market of Treatment of Musculoskeletal Diseases market is projected to reach €0.36bn by the year 2024.
It is anticipated that there will be an annual growth rate of 2.64% from 2024 to 2029, resulting in a market volume of €0.41bn by 2029.
When compared globally, United States is expected to generate the highest revenue of €55,790.00m in 2024.
Chile is witnessing a surge in demand for non-invasive treatment options for musculoskeletal diseases, leading to a rise in the adoption of physiotherapy and chiropractic services.

Key regions: Europe, Canada, United States, Germany, India

Marché

Région

Comparaison de régions

Monnaie

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.